BiondVax Pharmaceuticals Ltd. logo

BVXV

NASDAQ

BiondVax Pharmaceuticals Ltd.

SectorHealth CareIndustryBiotechnology: Biological Products (No Diagnostic Substances)IPO2015
$1.32-0.03 (-2.22%)
Website
News25/Ratings1

BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and related illnesses in Israel. The company was incorporated in 2003 and is headquartered in Jerusalem, Israel.

Latest news

25 items